Compounds of formula (1) are described: ##STR1## and the salts, solvates, hydrates and N-oxides thereof, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 have the meanings given in claim 1. The compounds are selective inhibitors of protein kinases, especially src-family protein kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to have a role.
公式(1)的化合物描述如下:##STR1##及其盐、溶剂合物、
水合物和N-氧化物,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6和R.sup.7具有权利要求书中给定的含义。这些化合物是蛋白激酶的选择性
抑制剂,特别是src家族蛋白激酶,并可用于预防和治疗免疫疾病、过度增殖性疾病和其他认为不当的蛋白激酶作用可能起作用的疾病。